Vera Therapeutics, Inc. (VERA) Misses Q2 EPS by 38c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $34.30 +0.65%
EPS Growth %: -27.8%
Financial Fact:
Product revenues: 280K
Today's EPS Names:
PMCB, PLCE, DOMO, More
EPS Growth %: -27.8%
Financial Fact:
Product revenues: 280K
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q2 EPS of ($1.20), $0.38 worse than the analyst estimate of ($0.82).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
- FuelCell Energy (FCEL) call put ratio 1 call to 1 put into quarter results
- Yext, Inc. (YEXT) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
